SCHEMBL7470065

SCHEMBL7470065

CCCc1[nH]c2ccc(C(=O)OC)cc2c1C(=O)C(C)C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.68
KMT2A Q03164 6/20 0.68
ATM Q13315 1/20 0.68
L3MBTL1 Q9Y468 1/20 0.68
KDM4E B2RXH2 5/20 0.47
ALDH1A1 P00352 5/20 0.47
HSD17B10 Q99714 4/20 0.47
HPGD P15428 3/20 0.47
GPR84 Q9NQS5 1/20 0.46
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
KIF11 P52732 2/20 0.44
HCRTR1 O43613 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MAPK1 P28482 2/20 0.41
ALOX12 P18054 1/20 0.41
MET P08581 1/20 0.41
FLT3 P36888 1/20 0.41
MAPT P10636 1/20 0.41
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7422800 0.91 KMT2A (0.58) MEN1KMT2AATML3MBTL1KDM4E
SCHEMBL7416657 0.81 MEN1 (0.65) MEN1KMT2AATML3MBTL1KDM4E
SCHEMBL7467512 0.81 KIF11 (0.51) MEN1KMT2AATML3MBTL1KDM4E
SCHEMBL7421225 0.77 KIF11 (0.50) MEN1KMT2AATML3MBTL1KDM4E
SCHEMBL7473716 0.77 KIF11 (0.50) MEN1KMT2AATML3MBTL1KDM4E
SCHEMBL7422734 0.77 KDM4E (0.44) MEN1KMT2AATML3MBTL1KDM4E
SCHEMBL7423432 0.77 KMT2A (0.62) MEN1KMT2AATML3MBTL1KDM4E
SCHEMBL7424222 0.76 HSD17B10 (0.43) MEN1KMT2AATML3MBTL1KDM4E
SCHEMBL7419842 0.76 KMT2A (0.60) MEN1KMT2AATML3MBTL1KDM4E
SCHEMBL7416246 0.75 ALOX5 (0.44) MEN1KMT2AATML3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed